Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Winston-Salem, North Carolina 27104


Purpose:

The purpose of this study tests whether beta-blocker will benefit asymptomatic patients with chronic primary mitral regurgitation.


Study summary:

The purpose of this study tests 1) whether Toprol xl, a beta-blocker will benefit asymptomatic patients with chronic primary mitral regurgitation; 2) investigate the effects of chronic mitral regurgitation on left ventricular remodeling, left ventricular function,exercise capacity and clinical symptoms.


Criteria:

Inclusion Criteria: - Diagnosis of sever primary mitral regurgitation - Normal subjects Exclusion Criteria: - Left ventricle ejection fraction of <55% pre and post operation - Pregnancy or Lactation - Secondary mitral regurgitation due to coronary artery disease, cardiomyopathy, uncontrolled hypertension, or severe aortic stenosis.


NCT ID:

NCT00700947


Primary Contact:

Principal Investigator
Min Pu, MD
The Wake Forest University


Backup Contact:

N/A


Location Contact:

Winston-Salem, North Carolina 27104
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: March 16, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.